 |
 |
Brooklyn |
Interview Transcript
 |
"I've been a cheerleader for two years."
Melinda (mother):
"Brooklyn loves cheerleading. That is what she does from sun up to sun down.
When Brooklyn turned about four years old, we noticed that children her age were quite a bit taller than she was, so we decided to go ahead and consult our doctor to find out why she wasn't growing.
Brooklyn was diagnosed with what they call idiopathic short stature.
We first heard about Nutropin from our doctor. We could see that when she was not growing that she was hurt that she realized that she was different from the other kids. And since [we] started taking the Nutropin, she has grown. She's out doing the things that she's always wanted to do."
Brooklyn:
"I'm looking forward to doing more and jumping higher, and I keep on trying to do the splits."
Melinda (mother):
"Genentech contacted us just right after we had talked to Dr. Thornton about the Nutropin, and a lady called and just told us that she would guide us the whole way through. And she did. I mean, all the support has been wonderful.
My hopes and dreams for Brooklyn are just that she grows, you know, to be whatever God intended her on being."
Product Indication Nutropin® [somatropin (rDNA origin) for injection] is indicated for the long-term treatment of growth failure due to a lack of adequate endogenous GH secretion.
Nutropin is also indicated for the treatment of growth failure associated with chronic renal insufficiency up to the time of renal transplantation. Nutropin therapy should be used in conjunction with optimal management of chronic renal insufficiency.
Nutropin is also indicated for the long-term treatment of short stature associated with Turner syndrome.
Nutropin is also indicated for the long-term treatment of idiopathic short stature, also called non-growth hormone-deficient short stature, defined by height SDS < -2.25, and associated with growth rates unlikely to permit attainment of adult height in the normal range, in pediatric patients whose epiphyses are not closed and for whom diagnostic evaluation excludes other causes associated with short stature that should be observed or treated by other means.
Important Safety Information Nutropin is not for children and teenagers whose bones have finished growing.
Nutropin is not for patients who have certain types of eye disease caused by diabetes.
Nutropin is not for patients who have active cancer or any brain tumors.
Nutropin is not for patients who are critically ill after open heart surgery or abdominal (stomach) surgery, are severely hurt, or have severe breathing problems.
Nutropin is not for children and teenagers who have Prader-Willi syndrome and are very overweight or have trouble breathing.
Patients who are about to start taking Nutropin, or are already taking it, must tell their doctor about all of the medications they are taking, including supplements; if they have or develop a brain tumor; if they are given any new medication — especially cortisone, hydrocortisone, prednisone, prednisolone, dexamethasone, triamcinolone, or betamethasone; if they are pregnant or if they become pregnant; about any other condition or illness they have or develop.
As with any injection, patients may experience discomfort, soreness, or redness where Nutropin is injected.
Patients should contact their doctor immediately if they experience ongoing injection site discomfort; curvature of the spine (scoliosis); joint pain; puffy hands and/or feet (caused by fluid retention); changes in vision, a bad headache, or nausea with or without vomiting; hip or knee pain; a need to limp when they walk; pain in wrist (carpel tunnel); allergic reactions.
Patients must inject Nutropin at a different recommended place on their body each time. The doctor or nurse should supervise the first injection and provide training and instruction.
Please see the full Product Information for additional safety information.
Individual results may vary.